FDA Grants Accelerated Approval to Iclusig With Chemotherapy for Newly Diagnosed Ph-positive ALL

The FDA granted accelerated approval to ponatinib (Iclusig, Takeda Pharmaceuticals U.S.A.) with chemotherapy for ...

MARCH 19, 2024